Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models
Published inPLOS Medicine, vol. 14, no. 7, e1002310
Publication date2017
Abstract
Keywords
- Animals
- Chelating Agents/pharmacology
- Male
- Molybdenum/pharmacology
- Rats
- Rats Wistar
- Reperfusion Injury/drug therapy
Research groups
Citation (ISO format)
DYSON, Alex et al. Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models. In: PLOS Medicine, 2017, vol. 14, n° 7, p. e1002310. doi: 10.1371/journal.pmed.1002310
Main files (1)
Article (Published version)
Identifiers
- PID : unige:98624
- DOI : 10.1371/journal.pmed.1002310
- PMID : 28678794
Journal ISSN1549-1277